Darwin Global Management »

Vaxcyte shares owned by Darwin Global Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Darwin Global Management from 13F filings

Historical chart of Darwin Global Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Darwin Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $36M 580k 62.80

More positions owned by Darwin Global Management

Ambrx Biopharma
Tg Therapeutics (TGTX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Vaxcyte (PCVX)
Springworks Therapeutics (SWTX)
Nuvalent Inc-a (NUVL)

View all positions for Darwin Global Management

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Braidwell
Jennison Associates
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte